Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
09/2005
09/09/2005WO2005061493A3 Polymorphic form b2 of ziprasidone base
09/09/2005WO2005058885A3 Piperidine derivatives and their use as glycine transporter inhibitors
09/09/2005WO2005058884A3 Cyclopropane compounds and pharmaceutical use thereof
09/09/2005WO2005032493A3 Amide compounds as ion channel ligands and uses thereof
09/09/2005WO2005009373A3 Tyrosine kinase inhibitors
09/09/2005CA2557541A1 Pyrimidine derivatives
09/09/2005CA2556768A1 Piperidinyl targeting compounds that selectively bind integrins
09/09/2005CA2556752A1 Heterocyclic self-immolative linkers and conjugates
09/09/2005CA2555720A1 Isoquinoline derivatives
09/08/2005US20050197375 Use of benzimidazole analogs in the treatment of cell proliferation
09/08/2005US20050197371 Urea derivatives as PDGFR modulators
09/08/2005US20050197364 Amide compounds as ion channel ligands and uses thereof
09/08/2005US20050197361 Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors
09/08/2005US20050197358 Administration of N-[4-(4-amino-2-ethyl-1H-imidazo[4,5-c]quinolin-1-yl)butyl]methanesulfonamide to induce cytokine biosynthesis or as a viricide or anticarcinogenic agent
09/08/2005US20050197353 E.g., N-[(S)-2-diphenylamino-1-(5-oxo-4,5-dihydro[1,3,4]oxadizol-2-yl)ethyl]-2-(2-methylaminopyrimidin-4-yl)-1H-indole-5-carboxamide; used for treating rheumatoid arthritis, osteoarthritis, asthma, cardiac infarction, Alzheimer's diseases, cancer diseases, atherosclerosis, etc.
09/08/2005US20050197350 Melanin Concentrating Hormone (MCH) receptor antagonist; clinical obesity; eating disorders; N-(cis-4-{[4-(dimethylamino)quinolin-2-yl]amino}cyclohexyl)-3-methoxy-benzamide; N-(2-chlorobenzyl)-N'-(cis-4-{[4- -(dimethylamino)-5,6,7,8-tetrahydroquinazolin-2-yl]amino}cyclohexyl)urea; pyrimidine analogs
09/08/2005US20050197347 Crystalline form having X-Ray powder diffraction pattern with peaks at 9.4, 13.7, 14.5, 14.9, 18.1, 20.2, 22.8+-0.2 degrees 2 theta; reacting salt of ziprasidone with alkaline agent and precipitating
09/08/2005US20050197346 Substituted heterocyclic compounds
09/08/2005US20050197336 2-[4-(naphtha-2-yl-4-sulfonyl)-piperazin-1-yl]-thiazole-5-carboxylic acid hydroxyamide; antiproliferative agent; synergestic mixture with other anticarcinogenic agents; cell cycle arrest, cellular differentiation, apoptosis and reversal of the trans-formed phenotype
09/08/2005US20050197334 triazoles and optionally carrier mixtures used for prohylaxis of infections, as antiproliferative agents, fungicides, bactericides, parasiticides, viricides, antiinflammatory agents and/or prokinetic agents (gastrointestinal modulatory)
09/08/2005US20050197331 Novel anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (NO) production
09/08/2005US20050197329 drugs such as 4-(4-{[amino(2-thienyl)methylidene]amino}phenyl)-N-(4-phenoxyphenyl)butanamide, used as nitric oxide synthase inhibitors and selective or non-selective traps for reactive oxygen species
09/08/2005US20050197327 Compounds, compositions, and methods
09/08/2005US20050197326 1,4-benzothiazin-3-ones that are optionally S-mono- or dioxygenated, quinoxazinones, quinolinones and benzapinones; peptide deformylase inhibitors, used for treating bacterial infections
09/08/2005US20050197325 Substituted spiro azabicyclics as modulators of chemokine receptor activity
09/08/2005US20050194561 Anionic-sweetener-based ionic liquids and methods of use thereof
09/07/2005EP1571145A1 Substituted piperidine compounds for use as H3 histamine receptor antagonists
09/07/2005EP1571144A1 Hydroxyalkylated cyclic diamine compound
09/07/2005EP1571142A1 Novel anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (NO) production
09/07/2005EP1570846A1 The novel coumarin-amide derivatives and its preparation, said drug composition and its use
09/07/2005EP1569932A1 Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2
09/07/2005EP1569931A1 Heterocyclic compounds as ccr5 antagonists
09/07/2005EP1569930A1 Indol derivatives and their use as 5-ht ligands
09/07/2005EP1569927A2 IMIDAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS
09/07/2005EP1569926A1 Carboxylic acid, phosphate or phosphonate substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators
09/07/2005EP1569925A1 2-substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators
09/07/2005EP1569910A2 Pesticidal sulphonylaminopyrazoles
09/07/2005EP1569901A2 ARYL, ARYLOXY, AND ALKYLOXY SUBSTITUTED i 1H /i -INDOL-3-YL GLYOXYLIC ACID DERIVATIVES AS INHIBITORS OF PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1)
09/07/2005EP1569653A1 Benzoxazin-3-ones and derivatives thereof as inhibitors of pi3k
09/07/2005EP1569637A1 Bicyclic-substituted amines as histamine-3 receptor ligands
09/07/2005EP1569633A2 Ca ix-specific inhibitors
09/07/2005EP1368342B1 Benzimidazole and pyridylimidazole derivatives as ligands for gaba receptors
09/07/2005EP1333824B1 Treatment of sexual dysfunction with bombesin receptor antagonists
09/07/2005EP1326853B1 Thiadiazoles and oxadiazoles and their use as phosphodiesterase-7 inhibitors
09/07/2005EP1289953B1 Serine protease inhibitors
09/07/2005EP1282621B1 Vitronectin receptor antagonists
09/07/2005EP1280801B1 Hydantoin-containing glucokinase activators
09/07/2005EP1254133B9 Indol-3-yl derivatives and their use as integrin inhibitors
09/07/2005EP1192132B1 Serine protease inhibitors
09/07/2005EP1189893B1 Substituted 2-aryl-1,2,4-triazine-3,5-di(thi)one
09/07/2005EP1188747B1 Phenoxypropylamine compounds
09/07/2005EP1042295B1 4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents
09/07/2005EP0888310B1 Cinnoline derivatives and use as medicine
09/07/2005CN1665904A Luminescent compositions
09/07/2005CN1665822A 1-thia-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
09/07/2005CN1665808A Thiadiazoles or oxadiazoles and their use as inhibitors of JAK protein kinase
09/07/2005CN1665800A Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions
09/07/2005CN1665792A Aryl- and heteroarylcarbonylpiperazines and their use for the treatment of benign and malignant oncoses
09/07/2005CN1665789A Diaminopyrimidinecarboxa mide derivative
09/07/2005CN1665787A Process for the preparation of 7-substituted-3-quinoline and 3-quinol-4-one carbonitriles
09/07/2005CN1217942C Pyrrolidine derivatives having phospholipase A inhibitory activity
09/07/2005CN1217940C Naphthol derivatives
09/07/2005CN1217936C Heterocyclic compounds having sulfonamide
09/07/2005CN1217932C Antibacterial agents
09/07/2005CN1217699C Preventives or remedies for arrhythmia
09/06/2005US6939988 Tricyclic compounds and their use in medicine process for their preparation and pharmaceutical compositions containing them
09/06/2005US6939882 Fungicides
09/06/2005US6939874 Substituted pyrimidinyl derivatives and methods of use
09/06/2005US6939866 Antitumor agents; skin disorders; anticancer agents
09/01/2005WO2005080976A1 Method of in vivo screening of therapeutic agent for memory/learning dysfunction by schizophrenia
09/01/2005WO2005080388A1 Viral polymerase inhibitors
09/01/2005WO2005080387A2 Processes for making pioglitazone and compounds of the processes
09/01/2005WO2005080382A1 Azabicyclo (3.1.0) hexane derivatives useful as modulators of dopamine d3 receptors
09/01/2005WO2005080378A1 Fused pyridazine derivatives
09/01/2005WO2005080377A1 COMPOUND HAVING TGF-β INHIBITORY ACTIVITY AND PHARMACEUTICAL COMPOSITION CONTAINING SAME
09/01/2005WO2005080376A1 Substituted spiro azabicyclics as modulators of chemokine receptor activity
09/01/2005WO2005080367A1 Ep2 receptor agonists
09/01/2005WO2005080360A1 Compounds
09/01/2005WO2005080359A1 Benzamide derivatives and their use as glucokinae activating agents
09/01/2005WO2005080358A2 Rosiglitazone phosphate and polymorphic forms
09/01/2005WO2005080346A1 Substituted azole derivatives, compositions, and methods of use
09/01/2005WO2005080344A1 Substituted azole compounds and thereof preparation and application
09/01/2005WO2005080335A1 3-3-di-substituted-oxindoles as inhibitors of translation initiation
09/01/2005WO2005080330A1 Heteroarylphenylurea derivative
09/01/2005WO2005079802A1 Bipyridyl amides as modulators of metabotropic glutamate receptor-5
09/01/2005WO2005079801A1 Pyrimidine compounds as purine receptor antagonist
09/01/2005WO2005079800A1 Pyrimidine compounds as purine receptor antagonist
09/01/2005WO2005079799A1 4-acyl-piperazines as anti-viral agents
09/01/2005WO2005079798A1 Pyrimidine derivatives and use thereof as agricultural and horticultural fungicides
09/01/2005WO2005079791A1 Thiophene -2- carboxylic acid - (1h - benzimidazol - 2 yl) - amide derivatives and related compounds as inhibitors of the tec kinase itk (interleukin -2- inducible t cell kinase) for the treatment of inflammation, immunological and allergic disorders
09/01/2005WO2005079378A2 Synthetic techniques and intermediates for polyhydroxy dienyl lactones and mimics thereof
09/01/2005WO2005066163A3 Thiophene derivatives as chk 1 inihibitors
09/01/2005US20050192441 Methods for the preparation of stereoisomerically enriched amines
09/01/2005US20050192440 Method for synthesizing epothilones and epothilone analogs
09/01/2005US20050192324 Novel dipeptidyl peptidase IV inhibitors; processes for their preparation and compositions thereof
09/01/2005US20050192314 Use of urea derivatives of isoxazoles; c-kit kinase inhibitors; anticancer agents; leukemias such as acute myelogenous leukemia (AML), and chronic myelogenous leukemias (CMLs)
09/01/2005US20050192313 Thio substituted with a hetero multiring group; sleepiness, promotion of wakefulness, Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain, attention deficit hyperactivity disorder
09/01/2005US20050192302 3-Cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors
09/01/2005US20050192300 Pyrimidine compounds
09/01/2005US20050192297 melanocortin-4 receptor (MC4-R) agonists; antidiabetic agents; non-insulin dependent diabetes; obesity
1 ... 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 ... 628